Related Experiment Video
Updated: Aug 4, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Imiquimod 5% cream (Aldara)
H B Slade1, M L Owens, M A Tomai
13M Pharmaceuticals, Medical Affairs Building 270-3A-01, St Paul, MN 55144-1000, USA. hbslade@mmm.com
Expert Opinion on Investigational Drugs
|July 5, 2005
Summary
Imiquimod cream effectively treats genital warts by stimulating the immune system, not by directly killing the human papillomavirus (HPV). This immune response leads to lasting clearance and suggests potential for other immune-related conditions.
Area of Science:
- Immunology
- Dermatology
- Virology
Background:
- Imiquimod is a novel immune-modifying molecule.
- Aldara (5% imiquimod cream) is used for external genital and perianal warts (Condyloma acuminata) caused by human papillomavirus (HPV).
Purpose of the Study:
- To review the efficacy and mechanism of action of imiquimod for treating external genital and perianal warts.
- To explore potential applications of imiquimod based on its immune-modulating effects.
Main Methods:
- Review of Phase III clinical trials for imiquimod in treating genital warts.
- Analysis of preclinical studies investigating imiquimod's effects on viral infections and tumor models.
- Examination of imiquimod's cytokine induction profile (IFN-alpha, TNF-alpha, IFN-gamma, IL-12).
Main Results:
- Imiquimod cream demonstrates good efficacy and safety for genital warts.
- The treatment works by inducing cytokines, leading to immune-based resolution of warts and reduced viral load.
- Complete clearance in Phase III trials suggests potential for long-term immunity.
- Preclinical studies show promise for herpes simplex virus, leishmaniasis, and a murine bladder cancer model.
- Imiquimod's ability to induce interferon-alpha suggests potential for treating conditions like basal cell carcinoma.
Conclusions:
- Imiquimod's self-application, tolerability, and unique immune-based mechanism make it a suitable first-line therapy for genital warts.
- Its immune-modulating properties warrant further investigation for various infectious and oncological conditions.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...